TREM2 and Alzheimer disease: Other medium-risk factors such as a rare missense mutation (R47H subsitiution) in the gene encoding the triggering receptor expressed on myeloid cells 2 (TREM2), which has in a normal situation an anti-inflammatory role in the brain, lead to an increased risk for AD through aberrant inflammatory processes (Jonsson et al., 2013).